Clinical trials
Completed Peri-Implantitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
180 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 1 |
| 2012 | 6 |
| 2013 | 9 |
| 2014 | 11 |
| 2015 | 6 |
| 2016 | 8 |
| 2017 | 14 |
| 2018 | 18 |
| 2019 | 11 |
| 2020 | 17 |
| 2021 | 13 |
| 2022 | 15 |
| 2023 | 18 |
| 2024 | 12 |
| 2025 | 7 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 180 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain | 9 |
| Universitat Internacional de Catalunya | 9 |
| Aristotle University Of Thessaloniki | 5 |
| Universidad Complutense de Madrid | 5 |
| Università Vita-Salute San Raffaele | 4 |
| Abant Izzet Baysal University | 3 |
| Göteborg University | 3 |
| Necmettin Erbakan University | 3 |
| OraPharma | 3 |
| University Medical Center Groningen | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peri-Implantitis | 180 |
| Periodontal Diseases | 17 |
| Periodontitis | 16 |
| Alveolar Bone Loss | 7 |
| Mucositis | 7 |
| Inflammation | 5 |
| Bone Diseases, Metabolic | 4 |
| Infections | 3 |
| Dental Caries | 2 |
| Dental Plaque | 2 |
Trials
Showing 51 to 75 of 180. Each trial links to its page on Pharma Observatory.
80 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.